Since we recently found that exogenous administration of GSSSG inhibits TCR signaling and protects allergen-induced airway inflammation (40), reduction of CARS2/CPERS expression in CD4+ T cells may enhance homeostatic proliferation via augmented TCR signaling. The gene discussed is CARS2; the disease is inflammation.